Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 1,216 other Healthcare companies
Ranked #226 of 1,217 · scores higher than 81% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including PRVA · Click a bar to see the companies
Mainly thanks to its earnings per share growth, revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 24.1% | 6.1% | 82% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 82.1% | 9.7% | 84% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 16.1% | 5.8% | 76% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 226 | 379.9B INR (≈$4.6B) | 81 | 55 | |
| 226 | 423M USD | 81 | 29 | |
| 226 | 124M USD | 81 | 31 | |
| 226 | 1.5B USD | 81 | 65 | |
| 226 | 2.7B USD | 81 | 56 | |
| 226 | 1.1B USD | 81 | 50 | |
| 226 | 271M SEK (≈$27M) | 81 | 41 | |
| 239 | 231.7B JPY (≈$1.6B) | 80 | 61 | |
| 239 | 5.9B HKD (≈$760M) | 80 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score